Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Ma

Showing results (851-860 of 864) with videos related to

Pageof 87
Sort By:
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Heart Rhythm|September 6, 2025
Ethanol Infusion of the Vein of Marshall in Catheter Ablation of Persistent Atrial Fibrillation in Patients with Mitral Valve ReplacementXiao-Hang Cheng, Xiao-Ying Liu, Wei Wang, et al.
Chinese Clinical Oncology|April 6, 2015
Expert consensus on local ablation therapies for primary liver cancerMeng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, et al.
Pacing and Clinical Electrophysiology : PACE|November 16, 2020
Withdrawal: Prospective randomized comparison between upgraded "2C3L" versus PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Cai-Hua Sang, De-Yong Long, et al.
Heart Rhythm|July 24, 2025
Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathyZhuo-Hang Du, Wei Wang, Xin Zhao, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 8, 2025
Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillationXue-Si Wang, Ze-Yang Wu, Qi Wu, et al.
American Heart Journal|February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
The New England Journal of Medicine|May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American Heart Association|July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCaroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology|October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Pageof 87

Showing results (851-860 of 864) with videos related to

Sort By:
Pageof 87
The New England Journal of Medicine|September 3, 2024
Asundexian versus Apixaban in Patients with Atrial FibrillationJonathan P Piccini, Manesh R Patel, Jan Steffel, et al.
Heart Rhythm|September 6, 2025
Ethanol Infusion of the Vein of Marshall in Catheter Ablation of Persistent Atrial Fibrillation in Patients with Mitral Valve ReplacementXiao-Hang Cheng, Xiao-Ying Liu, Wei Wang, et al.
Chinese Clinical Oncology|April 6, 2015
Expert consensus on local ablation therapies for primary liver cancerMeng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, et al.
Pacing and Clinical Electrophysiology : PACE|November 16, 2020
Withdrawal: Prospective randomized comparison between upgraded "2C3L" versus PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Cai-Hua Sang, De-Yong Long, et al.
Heart Rhythm|July 24, 2025
Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathyZhuo-Hang Du, Wei Wang, Xin Zhao, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 8, 2025
Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillationXue-Si Wang, Ze-Yang Wu, Qi Wu, et al.
American Heart Journal|February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
The New England Journal of Medicine|May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American Heart Association|July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCaroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology|October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Pageof 87